← Leaderboards
Hae Lin Jang
University Of California Los Angeles
$8,327,352
Attributed
$11,808,106
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,808,106 · 5
By mechanism
R01$9,408,107 · 4
R42$2,399,999 · 1
Top collaborators
- Shiladitya Sengupta8 shared
- Mehmet Remzi Dokmeci3 shared
- Ali Khademhosseini2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Flavia Pirih$1,268,285
- Jeremiah Easley$2,314,131
Others in their field
Other Emerging Leaders on “Injectable”
- Yunda Huang · Fred Hutchinson Cancer Center$58,397,458
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Laura McNay · Leidos Biomedical Research, Inc.$15,147,252
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Benjamin E Deverman · Broad Institute, Inc.$12,739,936
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
Research focus
InjectablePainInnovationIn VitroBoneAmericanBiomaterial CompatibilityOrganIn VivoBone TissueEngineeringPharmaceutical PreparationsOsteogenesisNanoparticleBone RegenerationQuality Of LifeMedicalAreaBone CementsSiteImmunoregulationPropertyOsteogenic3-Dimensional
Grant awards (19)
Next generation anti-cancer drugdelivering cement for bone metastasis patients$1,000,000
R42 · FY2025 · CA · contact PI
A novel bioengineering approach to restoring permanent periodontal inflammatory bone loss$814,498
R01 · FY2025 · DE · contact PI
Nanostructured degradable bone cement for delivering novel antibiotics$697,516
R01 · FY2025 · EB
Next generation anti-cancer drugdelivering cement for bone metastasis patients$1,000,000
R42 · FY2024 · CA · contact PI
A novel bioengineering approach to restoring permanent periodontal inflammatory bone loss$798,032
R01 · FY2024 · DE · contact PI
Nanostructured degradable bone cement for delivering novel antibiotics$683,565
R01 · FY2024 · EB
A novel bioengineering approach to restoring permanent periodontal inflammatory bone loss$834,068
R01 · FY2023 · DE · contact PI
Nanostructured degradable bone cement for delivering novel antibiotics$697,795
R01 · FY2023 · EB
Whitlockite nanoparticle-based immunotherapy for bone metastasis$531,867
R01 · FY2023 · CA
Whitlockite nanoparticle-based immunotherapy for bone metastasis$531,867
R01 · FY2022 · CA
3D printed muscle-bone organ implant for treating large injuries$417,860
R01 · FY2022 · AR
Next generation anti-cancer drugdelivering cement for bone metastasis patients$399,999
R42 · FY2022 · CA · contact PI
Whitlockite nanoparticle-based immunotherapy for bone metastasis$542,721
R01 · FY2021 · CA
3D printed muscle-bone organ implant for treating large injuries$414,418
R01 · FY2021 · AR
Whitlockite nanoparticle-based immunotherapy for bone metastasis$551,431
R01 · FY2020 · CA
3D printed muscle-bone organ implant for treating large injuries$432,174
R01 · FY2020 · AR
Whitlockite nanoparticle-based immunotherapy for bone metastasis$573,510
R01 · FY2019 · CA
3D printed muscle-bone organ implant for treating large injuries$433,024
R01 · FY2019 · AR
3D printed muscle-bone organ implant for treating large injuries$453,761
R01 · FY2018 · AR